Abstract
This study demonstrates the excellent diagnostic accuracy of the Xpert MTB/RIF test in patients with tuberculous lymphadenitis. The test sensitivity and specificity were 96.7% (95% confidence interval [CI], 86.6 to 100%) and 88.9% (95% CI, 69.6 to 100%), respectively, and it correctly identified 6/6 (100%) of the cytology smear-negative/culture-positive cases and 1 of 2 (50%) rifampin-resistant cases.
| Original language | English |
|---|---|
| Pages (from-to) | 3967-3970 |
| Number of pages | 4 |
| Journal | Journal of Clinical Microbiology |
| Volume | 49 |
| Issue number | 11 |
| DOIs | |
| Publication status | Published - 1 Nov 2011 |
| Externally published | Yes |
Fingerprint
Cite this
}
Xpert MTB/RIF for rapid diagnosis of tuberculous lymphadenitis from fine-needle-aspiration biopsy specimens. / Ligthelm, Louis J.; Nicol, Mark P.; Hoek, Kim G.P.; Jacobson, Rachael; Van Helden, Paul D.; Marais, Ben J.; Warren, Robin M.; Wright, Colleen A.
In: Journal of Clinical Microbiology, Vol. 49, No. 11, 01.11.2011, p. 3967-3970.Research output: Contribution to journal › Article
TY - JOUR
T1 - Xpert MTB/RIF for rapid diagnosis of tuberculous lymphadenitis from fine-needle-aspiration biopsy specimens
AU - Ligthelm, Louis J.
AU - Nicol, Mark P.
AU - Hoek, Kim G.P.
AU - Jacobson, Rachael
AU - Van Helden, Paul D.
AU - Marais, Ben J.
AU - Warren, Robin M.
AU - Wright, Colleen A.
PY - 2011/11/1
Y1 - 2011/11/1
N2 - This study demonstrates the excellent diagnostic accuracy of the Xpert MTB/RIF test in patients with tuberculous lymphadenitis. The test sensitivity and specificity were 96.7% (95% confidence interval [CI], 86.6 to 100%) and 88.9% (95% CI, 69.6 to 100%), respectively, and it correctly identified 6/6 (100%) of the cytology smear-negative/culture-positive cases and 1 of 2 (50%) rifampin-resistant cases.
AB - This study demonstrates the excellent diagnostic accuracy of the Xpert MTB/RIF test in patients with tuberculous lymphadenitis. The test sensitivity and specificity were 96.7% (95% confidence interval [CI], 86.6 to 100%) and 88.9% (95% CI, 69.6 to 100%), respectively, and it correctly identified 6/6 (100%) of the cytology smear-negative/culture-positive cases and 1 of 2 (50%) rifampin-resistant cases.
UR - http://www.scopus.com/inward/record.url?scp=80355141567&partnerID=8YFLogxK
U2 - 10.1128/JCM.01310-11
DO - 10.1128/JCM.01310-11
M3 - Article
VL - 49
SP - 3967
EP - 3970
JO - Journal of Clinical Microbiology
JF - Journal of Clinical Microbiology
SN - 0095-1137
IS - 11
ER -